Hydroxylation and glucosidation of ent-16β-Hydroxybeyeran-19-oic acid by Bacillus megaterium and Aspergillus niger

Planta Medica

Volumn 70, Issue 4, 2004, Pages 359-363

  Yang, Li Ming ^a,b   Hsu, Feng Lin ^a   Cheng, Juei Tang ^c   Chang, Cheng Hao ^a   Liu, Pan Chun ^a   Lin, Shwu Jiuan ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL RESEARCH INSTITUTE OF CHINESE MEDICINE   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Antihypertensive testing; Diterpenoids; ent 16 hydroxybeyeran 19 oic acid; Glucosidation; Microbial hydroxylation

Indexed keywords

16BETA HYDROXYBEYERAN 19 OIC ACID; 16BETA HYDROXYBEYERAN 19 OIC ACID ALPHA DEXTRO GLUCOPYRANOSYL ESTER; 1BETA,7ALPHA DIHYDROXY 16 OXOBEYERAN 19 OIC ACID; 1BETA,7ALPHA,16BETA TRIHYDROXYBEYERAN 19 OIC ACID; 7ALPHA,16BETA DIHYDROXYBEYERAN 19 OIC ACID; 7ALPHA,16BETA DIHYDROXYBEYERAN 19 OIC ACID ALPHA DEXTRO GLUCOPYRANOSYL ESTER; ANTIHYPERTENSIVE AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; ASPERGILLUS NIGER; BACILLUS MEGATERIUM; CONTROLLED STUDY; DRUG HYDROXYLATION; DRUG TRANSFORMATION; ENZYME ACTIVITY; GLUCOSIDATION; HYDROLYSIS; MALE; METABOLITE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; RAT;

ANTIHYPERTENSIVE AGENTS; ASPERGILLUS NIGER; BACILLUS MEGATERIUM; BIOTRANSFORMATION; DITERPENES, KAURANE; HUMANS; HYDROXYLATION; PHYTOTHERAPY;

ANIMALIA; ASPERGILLUS; ASPERGILLUS NIGER; BACILLUS MEGATERIUM; POSIBACTERIA;

EID: 2342544004     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-818949     Document Type: Article

References (12)

1. Ali HS, Hanson JR, de Oliveira BH. The biotransformation of some ent-beyeran-19-oic acids by Gibberella fujikuroi. Phytochemistry 1992; 31: 507-10
2. Hou CC. Studies on the active components from Bacopa monniera, Lactuca indica, and Stevia rebaudiana. Ph.D. Dissertation College of Pharmacy, Taipei Medical University, Taiwan: 2003: pp. 126-30
3. Lee CN, Wong KL, Liu JC, Chen YJ, Cheng JT, Chan P. Inhibitory effect of stevioside on calcium influx to produce antihypertension. Planta Med 2001; 67: 796-9
4. Fuganti C, Minut J, Fantoni P, Servi S. On the microbial transformation of α,β-unsaturated aryl ketones by the fungus Beauveria bassiana. J Mol Catal B: Enzym 1998; 4: 47-52
5. Adam W, Luckacs Z, Kahle C, Saha-Möller CR, Schreier P. Biocatalytic asymmetric hydroxylation of hydrocarbons by free and immobilized Bacillus megaterium cells. J Mol Catal B: Enzym 2001; 11: 377-85
6. Hsu FL, Hou CJ, Yang LM, Cheng JT, Liu PC, Lin SJ. Microbial transformations of isosteviol. J Nat Prod 2002; 65: 273-7
7. de Oliveira BH, dos Santos MC, Leal PC. Biotransformation of the diterpenoid, isosteviol, by Aspergillus niger, Penicillium chrysogenum and Rhizopus arrhizus. Phytochemistry 1999; 51: 737-41
8. Cheng JT, Hsu FL, Chen HF. Antihypertensive principles from the leaves of Melastoma candidum. Planta Med 1993; 59: 405-7
9. Chatterjee P, Pezzuto JM, Kouzi SA. Glucosidation of betulinic acid by Cunninghamella species. J Nat Prod 1999; 62: 761-3
10. Hammer E, Schoefer L, Schäfer A, Hundt K, Schauer F. Formation of glucoside conjugates during biotransformation of dibenzofuran by Penicillium canescens SBUG-M 1139. Appl Microbiol Biotechnol 2001; 57: 390-4
11. Kirkman SK, Zhang MY, Horwatt PM, Scatina J. Isolation and identification of bromfenac glucoside from rat bile. Drug Metab Dispo 1998; 26: 720-3
12. Kouzi SA, Chatterjee P, Pezzuto JM, Hamann MT. Microbial transformations of the antimelanoma agent betulinic acid. J Nat Prod 2000; 63: 1653-7 and references cited therein